Alembic Pharmaceuticals has informed that it has entered into a Joint Venture Agreement (JVA) dated 7th May, 2019 with SPH SINE Pharmaceutical Laboratories Co, China (SPH Sine) & Adia (Shanghai) Pharma, China (Adia).
The above information is a part of company’s filings submitted to BSE.